Intravitreal aflibercept in treatment-resistant pigment epithelial detachment
Author:
- 21 July 2016
- journal article
- research article
- Published by Springer Nature in International Ophthalmology
- Vol. 37 (3) , 531-537
Abstract
The purpose of the study was to assess the efficacy and safety of transition from ranibizumab to aflibercept intravitreal injections in treatment-resistant retinal pigment epithelial detachment (PED). The data of intravitreal ranibizumab treatment-resistant patients who have been switched to aflibercept treatment were reviewed retrospectively. After three monthly injections, bimonthly regimen was performed. The changes of PED height and radius, and the best-corrected visual acuity (BCVA) were analyzed retrospectively. Mean baseline PED height decreased from 297 ± 151 to 122 ± 42 µm at month 12 (P = 0.0007). Mean baseline PED radius decreased from 2371 ± 882 to 1859 ± 779 µm at month 12 (P = 0.0007). No complete PED resolution occurred in any of the patients at the end of the 12 months. Baseline BCVA improved from 0.63 ± 0.21 to 0.43 ± 0.17 logMar at month 12 (P = 0.0049). Mean BCVA gain was 1.4 decimal chart lines (7 letters) at month 12. Switching to aflibercept seems to have promising functional and anatomical outcomes with a reasonable complication rate in treatment-resistant PED.Keywords
This publication has 26 references indexed in Scilit:
- PROGRESSION OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPYRetina, 2016
- AFLIBERCEPT FOR THE TREATMENT OF RETINAL PIGMENT EPITHELIAL DETACHMENTSRetina, 2016
- Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapyBritish Journal of Ophthalmology, 2013
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Clinical features of drusenoid pigment epithelial detachment in age related macular degenerationBritish Journal of Ophthalmology, 2004
- ACUTE RETINAL PIGMENT EPITHELIAL TEAR AFTER PHOTODYNAMIC THERAPYRetina, 2001
- Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsNature Medicine, 2001
- Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularizationAmerican Journal of Ophthalmology, 2001
- [Retinal pigment epithelial detachment].1989
- Dehiscences of the pigment epithelium.1985